C-Reactive Protein Testing Market Size, Share & Trends Analysis Report
and Segment Forecast, 2025 | Grand View Research, Inc
“The global C-reactive protein test market size was estimated at USD 1.57
billion in 2016 and anticipated to expand at a CAGR of 1.3% over the forecast
period.”
The global C-Reactive Protein (CRP) Testing Market size is expected to reach USD 1.77 billion by 2025,
according to a new report by Grand View Research, Inc., exhibiting a CAGR of 1.3% during the forecast period.
Rising incidence of inflammatory disorders such as cancer infections and cardiovascular disorders is one of the
leading factors driving market growth. Furthermore, increasing global incidence of endometriosis in women is
expected to play a major role in the CRP testing market over the forecast period.
Increase in funds provided to academic research institutions and individual researchers is expected to boost
growth. Moreover, various initiatives by international bodies such as WHO and NIH for prevention and
treatment of chronic disorders such as cardiovascular diseases and cancer are anticipated to promote growth.
Point-of-care devices for CRP testing are being increasingly adopted by healthcare professionals in clinics and
hospitals. Technological advancements in these portable, rapid, and easy-to-use testing devices are expected to
strengthen POC settings. Additionally, collaborations among governments, companies, and research institutions
are expected to drive the growth of CRP diagnostic devices.
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/global-c-reactive-protein-testing-market
Further key findings from the report suggest:

By type of assay, immunoturbidimetric assays are estimated to account for the largest revenue share
owing to adequate availability of CRP testing kits based on this technology
Follow Us:

Based on disease type, cardiovascular disorders accounted for the largest market share owing to higher
clinical significance of CRP levels in disease-oriented studies for cardiac infections and strokes

On the basis of end use, clinics are estimated to account for the largest share in terms of revenue, owing
to favorable government policies in the field of primary healthcare settings

North America dominated the market due to presence of a well-established healthcare framework,
government support, increase in investigational studies in this field, and presence of a substantial
number of regional players

Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to presence of local
as well as international market players, extensive research, and favorable government support

Major players include Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd.;Ortho Clinical
Diagnostics; Quest Diagnostics; Danaher; Siemens Healthineers; Abbott; Abaxis, Inc.; Merck & Co., Inc.;
Laboratory Corporation of America Holdings; Getein Biotech, Inc.;Randox Laboratories Ltd.;BODITECH
MED, INC.; Orion Diagnostica Oy; and HORIBA, Ltd.

Companies are entering into collaborations with academic institutions and private and public entities to
promote advancements in the space, which is ultimately driving the growth of the C-reactive protein
testing market.
Grand View Research has segmented the global C-reactive protein testing market on the basis of assay type,
detection range, disease area, end use, and region:
C-Reactive Protein Testing Assay Type Outlook (Revenue, USD Million, 2014 - 2025)

Immunoturbidimetric assay

ELISA
o
Clinical
o
Nonclinical

Chemiluminescence immunoassay (CLIA)

Others
C-Reactive Protein Testing Detection Range Outlook (Revenue, USD Million, 2014 - 2025)

hs-CRP

Conventional CRP

cCRP
Follow Us:
C-Reactive Protein Testing Disease Area Outlook (Revenue, USD Million, 2014 - 2025)

Cardiovascular diseases

Cancer

Rheumatoid arthritis

Inflammatory bowel disease

Endometriosis

Lupus

Others
C-Reactive Protein Testing End-use Outlook (Revenue, USD Million, 2014 - 2025)

Clinics

Hospitals

Laboratories

Assisted living healthcare facilities

Home

Others
C-Reactive Protein Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)



North America
o
U.S.
o
Canada
Europe
o
Germany
o
U.K.
Asia Pacific
Follow Us:
o
Japan
o
China

Latin America
o

Brazil
Middle East and Africa (MEA)
o
Follow Us:
South Africa
Table of Content of C-Reactive Protein (CRP) Test Market
Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s Internal Database
1.2 Data Analysis
1.3 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 C-Reactive Protein Testing Market Variables, Trends & Scope
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 High R&D in the field of C-reactive protein testing
3.1.1.2 Rising burden of inflammatory disorders
3.1.2 Market restraint analysis
3.1.2.1 Availability of alternative disease testing methods
3.2 Penetration & Growth Prospect Mapping for Methods, 2016
3.3 C-Reactive Protein Testing Market-SWOT Analysis, By Factor (Political & Legal, Economic and
Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 C-Reactive Protein Testing: Assay Type Estimates & Trend Analysis
4.1 Global C-reactive protein testing Market: Assay Type Movement Analysis
4.2 Immunoturbidimetric Assay
4.2.1 Global immunoturbidimetric assay market, 2014 - 2025 (USD Million)
4.3 ELISA
4.3.1 Global ELISA market, 2014 - 2025 (USD Million)
4.3.2 Clinical
4.3.2.1 Global clinical market, 2014 - 2025 (USD Million)
4.3.3 Non-Clinical
Follow Us:
4.3.3.1 Global non-clinical market, 2014 - 2025 (USD Million)
4.4 Chemiluminescence Immunoassay (CLIA)
4.4.1 Global Chemiluminescence Immunoassay (CLIA) market, 2014 - 2025 (USD Million)
4.5 Others
4.5.1 Global others market, 2014 - 2025 (USD Million)
Chapter 5 C-Reactive Protein Testing: Detection Range Estimates & Trend Analysis
5.1 Global C-Reactive Protein Testing Market: Detection Range Movement Analysis
5.2 High sensitivity C-reactive protein
5.2.1 Global hsCRP market, 2014 - 2025 (USD Million)
5.3 Conventional CRP
5.3.1 Global conventional CRP market, 2014 - 2025 (USD Million)
5.4 Cardiac CRP (cCRP)
5.4.1 Global cardiac CRP market, 2014 - 2025 (USD Million)
Chapter 6 C-Reactive Protein Testing: Disease Area Estimates & Trend Analysis
6.1 Global C-reactive protein testing Market: Disease Area Movement Analysis
6.2 Cardiovascular diseases
6.2.1 Global cardiovascular diseases market, 2014 - 2025 (USD Million)
6.3 Cancer
6.3.1 Global cancer market, 2014 - 2025 (USD Million)
6.4 Rheumatoid Arthritis
6.4.1 Global rheumatoid arthritis market, 2014 - 2025 (USD Million)
6.5 Inflammatory bowel disease
6.5.1 Global inflammatory bowel disease market, 2014 - 2025 (USD Million)
6.6 Endometriosis
6.6.1 Global endometriosis market, 2014 - 2025 (USD Million)
6.7 Lupus
6.7.1 Global lupus market, 2014 - 2025 (USD Million)
6.8 Others
6.8.1 Global others market, 2014 - 2025 (USD Million)
Chapter 7 C-Reactive Protein Testing: End-Use Estimates & Trend Analysis
7.1 Global C-reactive protein testing Market: End-Use Movement Analysis
Follow Us:
7.2 Clinics
7.2.1 Global clinics market, 2014 - 2025 (USD Million)
7.3 Hospitals
7.3.1 Global hospitals market, 2014 - 2025 (USD Million)
7.4 Laboratories
7.4.1 Global laboratories market, 2014 - 2025 (USD Million)
7.5 Assisted living healthcare facilities
7.5.1 Global assisted living healthcare facilities market, 2014 - 2025 (USD Million)
7.6 Home
7.6.1 Global home market, 2014 - 2025 (USD Million)
7.7 Others
7.7.1 Global others market, 2014 - 2025 (USD Million)
Chapter 8 C-Reactive Protein Testing: Regional Estimates & Trend Analysis by Assay Type, Detection Range,
Disease Area, & End Use
8.1 C-reactive protein testing Market Share by Region, 2016 & 2025
8.2 North America
8.2.1 North America C-reactive protein testing market, 2014 - 2025 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
8.2.2.2 U.S. C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.2.2.3 U.S. C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.2.2.4 U.S. C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.2.3 Canada
8.2.3.1 Canada C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
8.2.3.2 Canada C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.2.3.3 Canada C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.2.3.4 Canada C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Europe C-reactive protein testing market, 2014 - 2025 (USD Million)
8.3.2 Germany
8.3.2.1 Germany C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
Follow Us:
8.3.2.2 Germany C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.3.2.3 Germany C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.3.2.4 Germany C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
8.3.3.2 U.K. C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.3.3.3 U.K. C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.3.3.4 U.K. C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific C-reactive protein testing market, 2014 - 2025 (USD Million)
8.4.2 Japan
8.4.2.1 Japan C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
8.4.2.2 Japan C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.4.2.3 Japan C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.4.2.4 Japan C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.4.3 China
8.4.3.1 China C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
8.4.3.2 China C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.4.3.3 China C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.4.3.4 China C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America C-reactive protein testing market, 2014 - 2025 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
8.5.2.2 Brazil C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.5.2.3 Brazil C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.5.2.4 Brazil C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa C-reactive protein testing market, 2014 - 2025 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
Follow Us:
8.6.2.2 South Africa C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
8.6.2.3 South Africa C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
8.6.2.4 South Africa C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
Chapter 9 Competitive Landscape
9.1 List of Companies
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Thermo Fisher Scientific, Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Ortho Clinical Diagnostics
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 F Hoffmann-La Roche Ltd.
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Danaher
9.3.4.1 Company overview
9.3.4.1.1 Beckman Coulter, Inc.
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Quest Diagnostics
9.3.5.1 Company overview
9.3.5.2 Financial performance
Follow Us:
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Siemens Healthineers
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Abbott
9.3.7.1 Company overview
9.3.7.1.1 Alere Inc.
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Abaxis, Inc.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Merck & Co., Inc.
9.3.9.1 Company overview
9.3.9.1.1 Sigma-Aldrich Co. LLC
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 LabCorp
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Getein Biotech, Inc.
9.3.11.1 Company overview
Follow Us:
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 HORIBA Ltd.
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Randox Laboratories Ltd.
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.13.4 Strategic initiatives
9.3.14 BODITECH MED, INC.
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 Orion Diagnostica Oy
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Follow Us:
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The global c-reactive protein (CRP) testing market size is expected to reach USD 1.77 billion by 2025, according to a new report by Grand View Research, Inc.